Cargando…
Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis()
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709825/ https://www.ncbi.nlm.nih.gov/pubmed/34977360 http://dx.doi.org/10.1016/j.medcle.2021.05.009 |
| _version_ | 1784623028889452544 |
|---|---|
| author | Callejas Rubio, José Luis Ríos Fernández, Raquel De la Hera Fernández, Javier |
| author_facet | Callejas Rubio, José Luis Ríos Fernández, Raquel De la Hera Fernández, Javier |
| author_sort | Callejas Rubio, José Luis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8709825 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87098252021-12-28 Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis() Callejas Rubio, José Luis Ríos Fernández, Raquel De la Hera Fernández, Javier Med Clin (Engl Ed) Scientific Letter Elsevier España, S.L.U. 2022-01-21 2021-12-25 /pmc/articles/PMC8709825/ /pubmed/34977360 http://dx.doi.org/10.1016/j.medcle.2021.05.009 Text en © 2021 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Scientific Letter Callejas Rubio, José Luis Ríos Fernández, Raquel De la Hera Fernández, Javier Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis() |
| title | Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis() |
| title_full | Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis() |
| title_fullStr | Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis() |
| title_full_unstemmed | Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis() |
| title_short | Efficacy and safety of SARS-CoV-2 vaccine in patients with giant cell arteritis() |
| title_sort | efficacy and safety of sars-cov-2 vaccine in patients with giant cell arteritis() |
| topic | Scientific Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709825/ https://www.ncbi.nlm.nih.gov/pubmed/34977360 http://dx.doi.org/10.1016/j.medcle.2021.05.009 |
| work_keys_str_mv | AT callejasrubiojoseluis efficacyandsafetyofsarscov2vaccineinpatientswithgiantcellarteritis AT riosfernandezraquel efficacyandsafetyofsarscov2vaccineinpatientswithgiantcellarteritis AT delaherafernandezjavier efficacyandsafetyofsarscov2vaccineinpatientswithgiantcellarteritis |